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type X collagen 
During the process of endochondral bone formation 
cpiphyseal cartilage undergoes a series of biochemical 
and cellular changes involving chondrocyte prolifera- 
tion, hypertrophy and matrix calcification which prc- 
part the cartilage for replacement by bone. Chondrocy- 
tes mature during this process in discrete differentiation 
steps as manifested by a change in the collagen type 
expression pattern. In the resting and proliferative zone 
chondrocytes synthesize type II, IX and XI collagen. 
but turn on type X collagen synthesis in the hypertro- 
phic zone [l--6]. Type X collagen, a short, network for- 
ming collagen [7,8] was originally found in cultures of 
fetal chondrocytes in monolayer [9], in organ cultures 
[lo]. on agar [ 1 l] and in collagen gels [12]. 
There is evidence from several studies that type X 
collagen is involved in cartilage calcification: (1) immu- 
nolocalization studies on samples of calcifying chick 
cartilage revealed type X collagen at sites of calcifica- 
tion [4,13]; (2) comparative studies of normal and rachi- 
tic chick epiphyseal cartilage showed an altered type X 
collagen synthesis in rachitic cartilage [14,15]; (3) in 
cultures of chick chondrocytes Ca” accumulation was 
determined during the onset of type X collagen synthe- 
sis [l&18]; (4) type X collagen has been shown to bind 
to matrix vesicles [ 16,191. These cell-derived membrane- 
inverted particles have been reported to initate calcifica- 
tion [20,21]. However, the role of type X collagen in 
calcification remains obscure. Here we present evidence 
for direct binding of Ca” to bovine and human type X 
collagen and on the occurrence of calcium deposits 
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within nodules of type X wllagcn produc$ng human 
chondrocytes cultured on agarosc. 
2. MATERIALS AND METHODS 
Culture medium was Ham’s modified F I2 (Scromed), supplemented 
with 10% fetal calf serum (G&co. Paisley. Scotland); 50 U/ml pnicillin 
and 50 &‘/ml streptomycin (Gibcoj. Agerose was obtained from BIO- 
Rad, ascorbic acid from Sigma Chemical Co. (SL Louis, MQ, USA). 
Cells were cultured at 37°C in 5% CO,, 95% air. 
2.2. Isolation o/ chondrocjws and ceil rutlure sonriilio~ 
Femoral head carlilagc (3S*week-old autopsied human fetus. 24 h 
postmortem) was dis.sccted fret from adhering connective tissue. 
cleaned. washed in phosphate-butTered saline pH 7.2 and digested for 
30 min at 37°C with 2 mgml trypsin (G&co) followed by digestion 
with collagenax (2 mgiml Worrhington) for g h ar 37OC. The released 
chondrocytes were cenlrifugcd and resuspended in culture medium 
(Ham’s Fl2 medium without ascorbic acid). 2 ml chondrocyte suspen- 
sion (3x 106cells/ml) was plated in IO-cm dishes previously coated with 
a thin layer of I .5% agarosc. Cells were fed by subsrituting half of the 
medium every 2- 3 days. 
For immunonuorescence sraining cells wcrr transferred on plaslic 
culture dishes (2x 10bcells/60-mm dish) and cultured for 24 h in Ham’s 
Fl2 medium supplemented with 50 pglrnl ascorbic acid and 4 Ujml 
hyaluronidase (Boehringer, Mannheim, Germany). Then AIS were 
washed with phospharc-buffered saline, fixed with 70% ethanol and 
air-dried. Immunofluorcscencc slaining was performed by incubation 
with rabbit anti collagen type X IgG for 3 h. Then after washing the 
cells were incubared with Texas red conjugated donkey anti rabbi1 IgG 
(Amersham) for I h. For demonstrating the localization of c;llCiUm 
dcposils, cells were stained with 0.5% hlizarine red S solulion pH 4.0 
for 5 min at room temperature. Conrrol cells wrrc decalcified with a 
solution of 300 mM EDTA! 50 mM Tris pH 7.5 for I h a1 room 
temperature prior staining. Stained cells were washed three times with 
water and ethanol. Cells were viewed under a L&z Diaplan micro- 
scope equipped for epilluorescerice. 
2.3. Isalatiutl of l,spcz X Collugm 
Type X collagen was isolated from bovine and human fetal growth 
pIale cartilage and purified as described previously 15.221. 
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2.4. PuriJiwlion of‘chondroculcin 2.6. f’rotetn cletemincrtion 
Chondrocalcin was isolated from fetal bovine growth plate cartilage Protein concentrations of sample\ were detcrmtncd according t0 
and purified by anion-cxchange chromatography on a Fast Q column Bradford (1976) [27] with the microassay proccdute dc\crthcd by Bio- 
and gel-filtration chromatography on a Superose 12 prep column Rad. 
(Pharmacia, Sweden) as described previously. Fraction C of the gel- 
filtration chromatography contained pure chondrocalcin [22]. 
Pepsin-extracted type II, IX and X1 collagens from fetal human or 
bovine epiphyseal cartilage wcrc purihcd by fractional salt precipita- 
tion as described elsewhere [23]. 
3. RESULTS 
2.5 (ir’ ’ binding cmwp 
2.5.1. Slot blot assay. 
Different concentrations of the purified proteins were applied onto 
nitrocellulose filters (Schleicher and Schuell) using a slot blot machi- 
nery. The labeling of proteins with %a” was carried out as described 
by Maryane et al. [24]. The nitrocellulose sheets were incubated in a 
solution containing 5 mM MgCI,, 60 mM KC1 and IO mM imidazole 
HCI pH 6.9 for 2 h with three changes of buffer. The nitrocellulose 
filters were then transferred to a new buffer containing 2 mCi of 
‘%aCl,/liter (I .7 mCi/mol) and incubated for 15 min at room tcmpc- 
rature. The filters were washed with 50% ethanol, tried and subjected 
to autoradiography. The proteins providing 4’CaZ+ were visualized by 
exposure to a Kodak XAR-5 film at -80°C. Band intensity was 
measured by scanning the nitroccllulosc filters. 
2.5.2. Solid phase %a” binding assay. 
To quantitate the Ca” binding known concentrations of purified 
bovine type X collagen (60 jrg) and chondrocalcin (60 ,ug) were cou- 
pled to Affigel IO beads (I ml suspension, Bio-Rad). Proteins were 
coupled in a solution containing 0.1 M MOW80 mM CaClz pH 7.5 
at 4°C overnight to the activated beads. After centrifugation the pro- 
tein concentration in the supernates was determined to calculate the 
coupling efficiency. Aliquots of 100~1 beads containing 4.7,ug of type 
X collagen were incubated with different concentrations of 4”CaCI, in 
a solution of 5 mM MgCI,, 60 mM KCI and IO mM imidazole HCI 
pH 6.8 for 1 h at room temperature. The beads were washed twice with 
the same buffer, and after centrifugation aliquots of the supernates 
were taken for scintillation counting. To determine the amount of 
bound %a” the beads were incubated with 300 mM EDTA/SO mM 
Tris pH 7.5 for 30 min and centrifuged; aliquots of the supernatcs were 
taken for scintillation counting. The amount of 45Ca” bound is ex- 
pressed as mol of Ca” bound/mol protein, assuming a molecular mass 
of 65 500 for bovine al(X) chain [25] and 35 000 for the 35-kDa 
subunit of chondrocalcin [26]. 
3.1 Mineral deposition in cultrrrr~i h,\pc,rttxphic chon- 
dtwytes 
When fetal human chondrocytes were grown on aga- 
rose in Ham’s Fl2 medium lacking ascorbic acid, most 
of the cells arranged into nodules. After transfer of these 
nodules to monolayer immunostaining with a polyclo- 
nal rabbit antibody against human type X collagen at 
the following day rcvcaled that after 28 days over 90% 
of the cells in the nodules showed a positive reaction 
(Fig. 1A). When aggregates of type X collagen synthesi- 
zing, hypcrtrophic chondrocytes were stained with Ali- 
zarine red S, calcium deposits were localized in the cen- 
ter of the nodules (Fig. 1 R). Staining was absent in 
nodules decalcified with EDTA prior staining (Kirsch 
et al., in preparation). The correlation between the 
staining for type X collagen and for calcium deposits in 
the center of chondrocyte nodules confirmed previous 
observations made in calcifying chick chondrocyte cul- 
tures [16-181, that type X collagen is involved in the 
calcification process. 
3.2. Cu2+ binding properties of type X coll~~gen 
To determine whether type X collagen has an affinity 
for calcium, various amounts of bovine and human type 
X collagen dotted onto nitrocellulose filters were incu- 
bated with 45Ca2’. Densitometric evaluation of the 
amount of bound radioactive calcium indicated that 
both bovine and human type X collagen bound calcium 
in a dose dependent manner. Chondrocalcin (C-pro- 
Fig. I. Localization of type X collagen (A) and calcium deposits (B) in nodules of human fetal chondrocytes cultured for 28 days on agar, and 
then transfered to monolayer for one day for immunostaining. Fixed cells were immunostained with an antibody against human type X collagen 
followed by Texas red conjugated donkey anti rabbit IgCi (A). Calcium deposits were detected by Alizarine red S staining (B). Note the correlation 
between type X collagen staining and Alizarine red S staining in the center of nodules. Bar, 50 pm. 
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Fig. 2. Ca” binding properties of bovine and human type X collagen. 
Different concentrations (50,20.10,5,1 ,&) of chondrocalcin. bovine 
type II, IX, X1 collagens and bovine and human type X collagen were 
applied onto nitrocellulosc filters and incubated with ?aClz (see 
section 2). Chondrocalcin, which ih known to bind calcium. was used 
as positive contl-ol. Autot-adlographs were analyzed by densitometry; 
the data are cxprcsscd as intcgratcd optical density for each band. The 
optical density obtained for the C‘a“ binding of 50 ,uug chondrocalcin 
was set as 100%. In contrast to type II, IX and XI collagen, bovine 
and human type X collagen showed a dose dependent binding of 
calcium. 
pcptide of type II collagen) that is known to be a 
calcium binding protein [2X] was used as positive con- 
trol. Other cartilage collagens, like type II, type IX and 
type XI collagen did not show any significant calcium 
binding (Fig. 2). 
To quantitate the Ca” binding to type X collagen, 
purified bovine type X was coupled to Affigel beads 
with a coupling efficiency of 70%. Aliquots of type X 
collagen beads were incubated with different concentra- 
tions of 4sCaC12. After centrifugation and washing, free 
calcium was determined by scintillation counting of the 
supernatants; bound calcium was released with EDTA 
from the beads and counted. As shown in Fig. 3A Cal’ 
bound to bovine type X collagen in a saturable manner, 
similar to Ca” binding to chondrocalcin (Fig. 3B). 
Analysis of the binding data by the method of Scatchard 
[29] (inserts of Fig. 3A,B) revealed that bovine type X 
collagen bound 15 calcium molecules per c1 chain with 
a Kd of-32pM. Chondrocalcin bound 6 calcium molecu- 
les per 35-kDa subunit with a Kd of -8 PM. 
4. DISCUSSION 
Immunohistological and in situ hybridization studies 
of different calcifying cartilages from chick and mam- 
malian species have documented the restriction of type 
X collagen to the hypertrophic and calcifying zone of 
cartilage [1,4-6,13,22,30]. In vitro it has been demon- 
strated by several investigators that hypertrophic, type 
X collagen synthesizing chondrocytes have the ability to 
calcify [16-l 81. Here we show that also in fetal human 
chondrocytes after four weeks culture on agarose cal- 
cium deposits can be detected by Alizarine red S 
staining in the center of the nodules. Mineral deposition 
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Fig. 3. High-affinity binding of Ca” to bovine type X collagen (A) and 
to chondrocalcin (C-propeptide of type II collagen, B). Experimental 
values for bound Ca*+ at different concentrations of free Cal’ were 
obtained as described in section 2 and were fitted to a binding curve. 
All values were determined three times, except the value for type X 
collagen at the highest 45CaZ’ concentration. The insets show the same 
data plotted according to Scatchard [28]. The amount bound (mol of 
Ca” bound per mol of bovine al(X) chain or the 35-kDa subunit of 
chondrocalcin) is plotted against bound/free where bound is again in 
mol/mol protein and free is the Ca” concentration (molar) in the 
supernates as determined by scintillation counting. Bovine type X 
collagen binds IS rnol of Ca” per mole of al(X) chain with a I& of 
approximately 32x IO “PM, while the 35-k&i subunit of chondrocal- 
tin binds 6 calcium molecules with a Kd of approximately 8x10-* PM. 
is preceded by type X collagen synthesis, suggesting that 
type X collagen plays a role in the mineralization. How- 
ever, the function of type X collagen in cartilage calcifi- 
cation remains unclear. A direct binding of calcium to 
type X collagen has never been shown. Here we present 
evidence for the calcium binding properties of bovine 
and human type X collagen. In contrast to type II, IX 
and XI collagens, type X collagen binds calcium with 
high affinity. Quantitative binding studies revealed that 
bovine type X collagen has 15 binding sites for Ca*’ per 
al(X) chain; these sites have values for K,, of about 32 
,uM. The type X collagen sequence does not contain 
calcium binding motifs [7,25,31]. But especially the C- 
terminal globular domains of the al(X) chains are rich 
in acidic amino acids that may bind calcium [25]. 
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The mechanism of cartilage mineralization during en- 
dochondral ossification is a complicated process and far 
from being completely understood. Several extracellular 
matrix proteins have been claimed to be involved in the 
calcification, including proteoglycans [32,33], the C- 
propeptide of type 11 collagen (chondrocalcin) [34], type 
X collagen [I], the matrix Gla protein [35] and osteonec- 
tin [36]. Matrix vesicles which have been reported to 
initiate mineralization [20,21] bind to type II and type 
X collagen [ 161, as well as to the link protein and hyalu- 
ronan-binding region of aggrecan [37]. Matrix vesicle 
proteins, belonging to the family of Ca-phospholipid 
binding annexins, are involved in these interactions [38-- 
401. Thus the data obtained in this study showing the 
Ca” binding properties of type X collagen suggest, that 
calcium may act as a mediator of the interaction of 
matrix vesicles with type X collagen. Further experi- 
ments have to confirm this hypothesis. 
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